Screener
Telomir Pharmaceuticals, Inc. TELO Q1 2026 earnings
Reported May 14, 2026 · After market close
EPS-$0.03Beat by $0.04
EPS estimate-$0.07
Next report
Dec 2, 2026 (in a month)Revenue estimate$500.0K
EPS estimate-$0.03
Versus estimates
Diluted EPS
FAQ
- When did Telomir Pharmaceuticals, Inc. report Q1 2026 earnings?
- Telomir Pharmaceuticals, Inc. (TELO) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were Telomir Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Telomir Pharmaceuticals, Inc. reported eps of $-0.03 for Q1 2026.
- Did Telomir Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.07 by $0.04.
- How did Telomir Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 57.1% from $-0.07.
- Where can I find Telomir Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-023010) directly on SEC EDGAR. The filing index links above go to sec.gov.
